Levocetirizine Dihydrochloride
Who holds supplier records for Levocetirizine Dihydrochloride? 14 organisations hold a current record for Levocetirizine Dihydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (11), Israel (1) and Hungary (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Levocetirizine Dihydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/levocetirizine-dihydrochloride
Reading the evidence
- 14 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
11 of the 13 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 9 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (14)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Levocetirizine Dihydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CHROMO LABORATORIES INDIA PRIVATE LTDIndiaCEPActive DMF 33219 · latest filing Mar 2019
- GLOCHEM INDUSTRIES LTDIndiaCEPActive DMF 21110 · latest filing Dec 2007
- Viyash Scientific LtdIndiaCEP Company GMP cert on recordActive DMF 22286 · latest filing Dec 2008
- ALIVUS LIFE SCIENCES LTDIndia Company GMP cert on recordActive DMF 22677 · latest filing Mar 2009
- CHONGQING HUAPONT PHARMACEUTICAL CO LTDActive DMF 23659 · latest filing Mar 2010
- Cipla LimitedIndia Company GMP cert on recordActive DMF 20173 · latest filing Jan 2007
- COHANCE LIFESCIENCES LTDIndia Company GMP cert on recordActive DMF 21417 · latest filing Mar 2008
- Granules India LimitedIndia Company GMP cert on recordActive DMF 22898 · latest filing May 2009
- JUBILANT BIOSYS LTDIndiaActive DMF 25279 · latest filing Mar 2012
- METROCHEM API PRIVATE LTDIndiaActive DMF 34731 · latest filing May 2020
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 21214 · latest filing Jan 2008
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 24343 · latest filing Dec 2010
- IndiaCEP Company GMP cert on record
- HungaryCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (5)
Certificates of Suitability on the EDQM register for Levocetirizine Dihydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 6 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| VIYASH SCIENTIFIC LIMITED Hyderabad | IN | CEP 2024-050 - Rev 02 Levocetirizine dihydrochloride | Jul 2026 | — |
| EGIS Pharmaceuticals PLC Budapest | HU | CEP 2023-391 - Rev 00 Levocetirizine dihydrochloride | Nov 2025 | Inspected Nov 2025 Hungary |
| GLOCHEM INDUSTRIES PRIVATE LIMITED Hyderabad | IN | CEP 2024-049 - Rev 00 Levocetirizine dihydrochloride | Mar 2025 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2024-171 - Rev 00 Levocetirizine dihydrochloride | Dec 2024 | — |
| CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram | IN | CEP 2023-225 - Rev 00 Levocetirizine dihydrochloride | Jul 2024 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Levocetirizine Dihydrochloride are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- Netherlands · Inactive DMF 24561 · filed Jan 2011
- Israel · Inactive DMF 24161 · filed Aug 2010
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Levocetirizine Dihydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201190).
Chemical identity
- IUPAC name
- 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride
- Canonical SMILES
- C1CN(CCN1CCOCC(=O)O)[C@H](C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl
- InChIKey
- PGLIUCLTXOYQMV-GHVWMZMZSA-N
- Synonyms
- Cetirizine hydrochloride (r)-, Cetirizine (r)-form dihydrochloride, Levocetirizine dihydrochloride, Levocetirizine hydrochloride, Levocetirizine monohydrochloride, NSC-758898, UCB 28556, UCB-28556, Xusal, Xyzal, Xyzal allergy 24hr, Xyzall
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Histamine-1 Receptor Antagonist
- Mechanism of action
- Histamine H1 Receptor Antagonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Levocetirizine Dihydrochloride?
14 organisations hold an active US FDA Type II Drug Master File or a CEP for Levocetirizine Dihydrochloride: CHROMO LABORATORIES INDIA PRIVATE LTD (India), GLOCHEM INDUSTRIES LTD (India), Viyash Scientific Ltd (India), ALIVUS LIFE SCIENCES LTD (India), CHONGQING HUAPONT PHARMACEUTICAL CO LTD, Cipla Limited (India), COHANCE LIFESCIENCES LTD (India) and Granules India Limited (India), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Levocetirizine Dihydrochloride Drug Master Files are active?
CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 33219), GLOCHEM INDUSTRIES LTD (DMF 21110), Viyash Scientific Ltd (DMF 22286), ALIVUS LIFE SCIENCES LTD (DMF 22677), CHONGQING HUAPONT PHARMACEUTICAL CO LTD (DMF 23659), Cipla Limited (DMF 20173), COHANCE LIFESCIENCES LTD (DMF 21417) and Granules India Limited (DMF 22898) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Levocetirizine Dihydrochloride records mean?
2 organisations have only inactive Type II DMFs for Levocetirizine Dihydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Levocetirizine Dihydrochloride have a European Certificate of Suitability?
Yes. 5 organisations hold a valid CEP for Levocetirizine Dihydrochloride on the EDQM register, including VIYASH SCIENTIFIC LIMITED Hyderabad (IN), EGIS Pharmaceuticals PLC Budapest (HU), GLOCHEM INDUSTRIES PRIVATE LIMITED Hyderabad (IN), DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN) and CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Levocetirizine Dihydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Levocetirizine Dihydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.